RETeval Study for Diabetic Retinopathy

NACompletedINTERVENTIONAL
Enrollment

468

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Diabetic Retinopathy
Interventions
DEVICE

RETeval

RETeval is a new handheld device intended to detect vision threatening diabetic retinopathy by measuring the response of the retina to a flash of light.

Trial Locations (2)

30033

Atlanta VA Medical Center, Decatur

73104

Oklahoma City VA Medical Center, Oklahoma City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

LKC Technologies, Inc.

INDUSTRY

collaborator

National Eye Institute (NEI)

NIH

lead

Inoveon Corporation

INDUSTRY